comparative effectiveness of semaglutide and tirzepatide vs bariatric surgery A network meta-analysis backed weight-loss benefits with several GLP-1 receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Comparison of Clinical Efficacy and

Researchers say their findings mean that GLP-1s should be considered as a potential treatment for respiratory diseases

Risk of bias assessment The risk of bias of the included studies was assessed independently by paired reviewers according to a modified Cochrane risk of bias tool [22]

Simvastatin impairs insulin secretion by multiple mechanisms in MIN6 cells

Some reports suggest that the interaction between GLP-1 drugs and psilocybin mushrooms can lead to: Delayed onset (2+ hours) Blunted or unpredictable effects Abrupt drop-offs instead of a gradual taper Non-event experiences where no noticeable effects occur This is an important topic for several reasons, including control, safety, and proper expectation-setting

Semaglutide is a synthetic 31-amino-acid analogue of the human incretin hormone glucagon-like peptide-1 (GLP-1), engineered to resist enzymatic degradation and bind serum albumin